4
Changes in Ownership
4D Molecular Therapeutics, Inc. Filed Acc 0000950170-24-023330
Chief Legal Officer sold 1,909 shares at $30.00 ($57,270)
- Chief Legal Officer acquired 1,909 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Bizily Scott Chief Legal Officer | 2024-02-27 | Option exercise 10b5-1 | +1,909 | $20.24 | $38,638 | 3,646 | D: show line 1 in the form |
| Bizily Scott Chief Legal Officer | 2024-02-27 | Sale 10b5-1 | −1,909 | $30.00 | $57,270 | 1,737 | D: show line 2 in the form |
| Open-market sales · 1,909 sh · avg $30.00 · $57,270 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Bizily Scott Chief Legal Officer | 2024-02-27 | Option exercise · Stock Option (Right To Buy) 10b5-1 | −1,909 | 48,091 | D: show line 3 in the form |
Loading xslF345X05/ownership.xml…